Marijuana Company of America, Inc. (OTC: MCOA) is building upon its vertically integrated business strategy by taking a unique approach to how companies within the industry position themselves in the marketplace.
Marijuana Industry
Cannabis Biotechs Could be Big Pharma’s Latest M&A Focus
InMed’s promising biosynthesis platform could put it on the radar of some major names seeking entry into one the pharmaceutical industry’s fastest-growing sectors.
How Biosynthesis is Revolutionizing Cannabinoid Pharmaceuticals
Biosynthesis gives manufacturers the ability to produce a high-quality and consistent active ingredient every time, eliminating concerns of crop variability and pesticide contaminants while greatly reducing cost.
Investors Could Reap Global Rewards of Research into Medical Cannabis Science
Cannabis companies have ramped up their efforts to make new scientific discoveries related to the plant’s medical uses.
Cannabis Demand in Canada Creates Considerable Opportunity for ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF)
As Canada prepares for the legalization of recreational marijuana in July 2018, analysts are noting a shortage of supplies compared to expected demand for cannabis products.
Marijuana Company of America, Inc. (MCOA) Builds Momentum as Legalization Push Gains Steam
Marijuana Company of America (OTC: MCOA) is strongly positioned as the cannabis market continues to relentlessly expand throughout the country. In an effort to keep up with the increasing demand, the company entered an agreement with Bougainville Ventures to build a new structure.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Enters the Multibillion-Dollar Tea Market
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has developed delivery technologies to improve absorption of bioactive compounds and intends to use that technology in the tea market.
Grey Cloak Tech, Inc. (GRCK) Enters CBD Market through Strategic Acquisition
Grey Cloak Tech recently entered the booming cannabis industry through the strategic acquisition of a medically-focused CBD company, Eqova Life Sciences.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Targets Global Cannabis Market
ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America.
Biotech M&A Momentum Attractive for Cannabinoid R&D Space
With growing interest in the convergence of cannabis and medicine, companies like InMed Pharmaceuticals may find themselves on the radar of Big Pharma.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Driving Cannabis Costs Down While Meeting Patient Needs
Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, is creating a consistent, organically grown, pesticide-free standardized product that is keeping costs down and investors excited.
As Bitcoin Boom Continues, Major Players are Validating Promising Forecasts for its Limitless Value Potential
SinglePoint is very close to launching its own bitcoin exchange aimed at solving the current problems of unbankability for cannabis businesses in the United States.
Grey Cloak Tech Inc. (GRCK) is “One to Watch”
Grey Cloak Tech Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, targets the rapidly growing cannabinoid (CBD) market through its wholly owned subsidiary Eqova Life Sciences.
What the California Fires Mean for the Weed Industry - Rolling Stone
What the California Fires Mean for the Weed Industry
Weed is the new craft beer, says former Budweiser exec: 'Ignore it at your peril' - From Financial Post
Chris Burggraeve is one of many entrepreneurs and investors increasingly flocking to the cannabis industry from the traditional business world